Qube Research & Technologies (QRT)
ATYR

Qube Research & Technologies (QRT)’s aTyr Pharma ATYR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.8K Buy
+126,996
New +$83K ﹤0.01% 3058
2025
Q2 		– Sell
-414,592
Closed -$1.25M – 4062
2025
Q1 		$1.25M Sell
414,592
-15,432
-4% -$56.3K ﹤0.01% 2171
2024
Q4 		$1.56M Buy
430,024
+290,869
+209% +$881K ﹤0.01% 1983
2024
Q3 		$245K Buy
139,155
+138,967
+73,919% +$253K ﹤0.01% 2509
2024
Q2 		$294 Sell
188
-9,456
-98% -$16.5K ﹤0.01% 3361
2024
Q1 		$18.8K Buy
9,644
+9,456
+5,030% +$16.5K ﹤0.01% 3704
2023
Q4 		$265 Hold
188
– – ﹤0.01% 3960
2023
Q3 		$297 Buy
+188
New +$348 ﹤0.01% 3716
2022
Q1 		– Sell
-11,665
Closed -$87K – 3110
2021
Q4 		$87K Buy
+11,665
New +$97.3K ﹤0.01% 2169

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ATYR Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in aTyr Pharma (ATYR) in Q2 2026: 126,996 shares worth $75.8K. The stake represents ﹤0.01% of the portfolio and ranks #3058 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ATYR as recently as Q1 2025.

Qube Research & Technologies (QRT) first reported a position in ATYR in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.56M in Q4 2024. 89 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Qube Research & Technologies (QRT) held 126,996 shares of aTyr Pharma worth $75.8K as of Q2 2026.
  • aTyr Pharma was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3058 holding.
  • Qube Research & Technologies (QRT) first reported a position in aTyr Pharma in Q4 2021 and has held it in 9 quarters since.
  • Qube Research & Technologies (QRT)'s aTyr Pharma position peaked at $1.56M in Q4 2024.
  • 89 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.